Revolutionizing Pharma Supply Chains with EPCIS 2.0 and CBV

The pharmaceutical industry is constantly seeking ways to improve the transparency and efficiency of its supply chain. One groundbreaking solution that is revolutionizing the pharma supply chain is the combination of EPCIS 2.0 (Electronic Product Code Information Services) and CBV (Core Business Vocabulary).

EPCIS 2.0 is a standard for capturing and sharing real-time information about the movement and status of products as they travel through the supply chain. It provides visibility into the journey of pharmaceutical products from manufacturing to distribution and helps in tracking and tracing the products effectively.

CBV, on the other hand, is a standardized vocabulary of common business concepts and processes that can be used across different industries. When combined with EPCIS 2.0, CBV helps in standardizing the data that is captured and shared within the supply chain, making it easier for different stakeholders to understand and utilize the information.

Together, EPCIS 2.0 and CBV offer several benefits to the pharma supply chain:

  1. Improved Traceability: With EPCIS 2.0 and CBV, pharmaceutical companies can accurately trace the movement of products, enabling them to quickly identify and address any issues related to product recalls, counterfeiting, or quality control.

  2. Enhanced Transparency: By standardizing the data across the supply chain, EPCIS 2.0 and CBV ensure that all stakeholders have access to consistent and reliable information, promoting trust and transparency in the process.

  3. Efficient Compliance: The use of EPCIS 2.0 and CBV helps pharma companies comply with regulatory requirements and industry standards by providing a structured way to capture and share supply chain data.

  4. Streamlined Operations: The standardization of data through EPCIS 2.0 and CBV simplifies the integration of different systems and processes within the supply chain, leading to more efficient operations and reduced costs.

In conclusion, the combination of EPCIS 2.0 and CBV is revolutionizing the pharma supply chain by providing unprecedented visibility, traceability, and efficiency. Pharmaceutical companies that adopt these standards can expect to improve their supply chain management, enhance regulatory compliance, and ultimately deliver better products to the market.

Back to Blog